JUVÉDERM® is the World’s #1 brand of hyaluronic acid Facial Fillers1*: Our full range of hyaluronic acid (HA) facial fillers is built on Allergan’s Aesthetics an AbbVie company heritage of quality, science and meaningful innovation.2 Each gel is carefully designed with specific properties to address the most popularly treated areas of the face.3¶
*Based on HCP tracking market research, from over 1000 HCPs in the largest 13 aesthetic markets worldwide.
¶ Based on market research involving 756 healthcare professionals from 12 must win markets.
1. Allergan. Unpublished Data. INT/0771/2016(2). JUVÉDERM®, the world’s leading brand of hyaluronic acid facial fillers. Feb 2019.
2. Stephens H. 2000. Allergan’s first fifty years. Lyme, CT: Greenwich Pub. Group.
3. Allergan. Unpublished Data. INT/0023/2017(1). The most treated areas of the face. Feb 2019.
* The products are intended for professional use only.
Hyaluronic acid gel (24mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 0.55mL
Hyaluronic acid gel (24mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (24mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (24mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 0.55mL
Hyaluronic acid gel (12mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (15mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (17,5mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (17,5mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 0.55mL
Hyaluronic acid gel (20mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Hyaluronic acid gel (25mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Report an Adverse Event
Adverse Events must be reported to Allergan Aesthetics an AbbVie Company (tel: 2144165555, email: greekpv@abbvie.com) and
For events from the use of a medical device, for Greece: tel. 2132040528/542 or visit the website: https://www.eof.gr/ web/ guest/ whitegeneral or via email at: vigilancematerial@eof.gr, and for Cyprus: tel. 22 605785/735/572 or via email at: cymda@mphs.moh.gov.cy.